深圳微芯生物科技股份有限公司关于持股5%以上股东减持股份计划的公告

Group 1 - The major shareholder, Bio-Ocean Biological Group Co., Ltd., holds 34,705,162 shares of Microchip Biotech Co., Ltd., accounting for 8.51% of the total share capital [2] - Bio-Ocean plans to reduce its holdings by up to 12,233,893 shares, which is no more than 3% of the total share capital, within six months starting from 15 trading days after the announcement [3] - The reduction will be executed through a combination of centralized bidding and block trading, with specific limits on the number of shares that can be sold in any 90-day period [3] Group 2 - The reduction plan is driven by strategic funding needs and will not significantly impact the company's governance structure or ongoing operations [6] - The company will adjust the number of shares to be reduced in case of any corporate actions such as dividends or stock splits during the reduction period [3] - The selling price will be determined based on market conditions and will comply with relevant regulations [3]